Word: upjohn
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...company always struck analysts as something of a black sheep. The Monsanto Company, whose subsidiary Searle makes the wildly successful arthritis drug Celebrex, has been casting around for a merger partner for over a year, and now, executives say, the search is over. Monsanto will merge with Pharmacia & Upjohn, joining the ranks of other mega-merger firms like Astra-Zeneca and Rhone-Poulenc-Hoechst, to form a corporation worth about $52 billion. Why did it take so long for Monsanto to find its mate, and why was Pharmacia willing to take it on? The answers lie in Monsanto's agri...
...heart of the company's agribusiness. Those inklings of dissent were enough, apparently, to make up executives' minds: They would complete a merger and quickly cut the agribusiness free from the rest of the company, letting it fend for itself. That amputation, execs hope, will leave Monsanto and Pharmacia & Upjohn's pharmaceuticals division to take the market by storm - unhindered by bad publicity...
Even after marketing Rogaine for the past decade, Pharmacia & Upjohn isn?t posting the profits it should be. According to Monday?s Wall Street Journal, income from Rogaine is slumping behind that of Merck?s Propecia - the market?s other, more powerful anti-baldness drug. It seems that in the course of wooing balding men, Pharmacia & Upjohn has tripped over its own advertising claims: The Rogaine web site boasts that the product is ?medically proven to regrow hair,? while following pages back away from such strong language, focusing instead on various caveats to be kept in mind by prospective users...
...Street Journal reports, the makers of Rogaine are putting a new, happy face on their product, pitching it as a preventive measure to men who simply want to hang on to the hair they?ve got. ?Rogaine? trumpet the latest ads, ?Stronger than heredity.? The marketing mavens at Pharmacia & Upjohn may be onto an elemental truth: Men who are worried about losing their hair are far more obsessive about their scalps than men who have actually stared into the shiny face of baldness. And in the ongoing tradition of avoidance, this new marketing tack allows men who harbor dark fears...
COMFORT AND CONFIDENCE Incontinence affects an estimated 17 million Americans, but only some 20% seek help. Women are the most frequent sufferers because the condition is often linked to menopause. Pharmacia & Upjohn is rolling out a bladder-control drug called Detrol this spring. The pill is the first such medication to win federal approval in more than 20 years...